Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.42 |
| ▸ | CD69 | Q07108 | 1/20 | 0.42 |
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PYGB | P11216 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27921424 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| SCHEMBL8648898 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| SCHEMBL19475556 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| SCHEMBL460988 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| SCHEMBL7094225 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| SCHEMBL2413753 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| SCHEMBL25166887 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| SCHEMBL181028 | 1.00 | LMNA (0.43) | LMNAKDM4EALOX15LGALS8CD69 | |
| Hydrochloric Acid SCHEMBL28256651 | 0.98 | LMNA (0.42) | LMNAKDM4EALOX15LGALS8CD69 | |
| Ammonia Solution, Strong SCHEMBL27636528 | 0.98 | LMNA (0.42) | LMNAKDM4EALOX15LGALS8CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3749775-A1 | IMPROVED METHOD FOR MEASUREMENT OF MICROBIAL BIOMASS | Mycometer A/S (DK) | 2020-12-16 | — | — | EP | claimed |
| WO-2019154898-A1 | IMPROVED METHOD FOR MEASUREMENT OF MICROBIAL BIOMASS | MYCOMETER A/S (DK) | 2019-08-15 | — | — | WO | claimed |
| CN-101666723-B | Method for detecting N-acetyl-beta-D-glucosaminidase electrophoresis reactive dye | XIAMEN UNIVERSITY (CN) | 2011-12-14 | — | — | CN | claimed |
| CN-101666723-A | Method for detecting N-acetyl-beta-D-glucosaminidase electrophoresis reactive dye | UNIV XIAMEN | 2010-03-10 | — | — | CN | claimed |
| EP-1573047-A4 | LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | GENITRIX LLC (US) | 2008-06-25 | — | — | EP | claimed |
| EP-1573047-A2 | LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | Genitrix LLC (US) | 2005-09-14 | — | — | EP | claimed |
| WO-2004018698-A2 | LECTIN COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE TO AN ANTIGEN | GENITRIX, LLC (US) | 2004-03-04 | — | — | WO | claimed |
| EP-1053243-A1 | SPHINGOLIPID DERIVATIVES AND THEIR METHODS OF USE | EMORY UNIVERSITY (US) | 2000-11-22 | — | — | EP | claimed |
| WO-1999041266-A9 | SPHINGOLIPID DERIVATIVES AND THEIR METHODS OF USE | UNIV EMORY (US) | 2000-11-16 | — | — | WO | claimed |
| WO-1999041266-A1 | SPHINGOLIPID DERIVATIVES AND THEIR METHODS OF USE | EMORY UNIVERSITY (US) | 1999-08-19 | — | — | WO | claimed |
| CN-111175099-B | Extraction and tabletting method for body fluid cells for detecting bladder cancer | 湖北泰康医疗设备有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-111826417-B | N-acetyl-beta-D-glucosaminidase detection kit with good stability, preparation method and application | 武汉生之源生物科技股份有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-11414641-B2 | Article and method for detecting aerobic bacteria | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-08-16 | — | — | US | disclosed |
| US-11092565-B2 | Electrochemical methods and compounds for the detection of enzymes | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-08-17 | — | — | US | disclosed |
| US-20210087516-A1 | ARTICLE AND METHOD FOR DETECTING AEROBIC BACTERIA | 3M INNOVATIVE PROPERTIES COMPANY | 2021-03-25 | — | — | US | disclosed |
| WO-2001004341-A1 | METHOD FOR PRODUCING OLIGOPOLYSACCHARIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2001-01-18 | — | — | WO | disclosed |
| EP-1040098-A1 | INTEGRIN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (a New Jersey corp.) (US) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999031061-A1 | INTEGRIN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| EP-0294804-A2 | Method for determination of NAGase and reagent therefor | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1988-12-14 | — | — | EP | disclosed |
| EP-0294804-A2 | Method for determination of NAGase and reagent therefor | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11092565-B2 | Electrochemical methods and compounds for the detection of enzymes | EPX, DNASE1, DERA | LMNA 1560/4885KDM4E 3018/4885ALOX15 1749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.